Effective Communication About Lung Cancer Screening Without Iatrogenic Stigma: A Brief Report Case Study Using the Lung Cancer Stigma Communications Assessment Tool of LungTalk
Stigma thwarts progress in lung cancer risk reduction and control and adversely affects patients across the entire lung cancer care continuum. In developing and disseminating patient and public-facing interventions to increase lung screening, we must be cognizant of how communications have the potential for further stigmatization of at-risk populations. Creation of the Lung Cancer Stigma Communications Assessment Tool (LCS-CAT) version 1 was supported by the American Cancer Society’s National Lung Cancer Roundtable to help content developers identify, remove, and replace potentially stigmatizing language and imagery from materials designed to engage individuals across the lung cancer continuum.
Explore More
Cancer Statistics Center
The ACS’ Cancer Statistics Center website gives the user an opportunity to explore, interact with, and share cancer statistics.
Updates Regarding Biomarker Testing For Non–Small Cell Lung Cancer: Considerations From The National Lung Cancer Roundtable
Updates Regarding Biomarker Testing For Non–Small Cell Lung Cancer: Considerations From The National Lung Cancer Roundtable
Accelerating Uptake of Lung Cancer Screening Summit Executive Summary
The American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) held its inaugural summit on Accelerating Uptake of Lung Cancer Screening on July 19-20, 2022, in Washington, DC. Increasing lung cancer screening has long been a priority of the NLCRT and its members. The goal of the summit was to accelerate the uptake of lung cancer screening by creating a shared understanding of the current state of screening, identifying key challenges and barriers, and developing and prioritizing strategies to build a comprehensive framework that engages key partners with actionable recommendations.